The Gingival Recession market, estimated at USD 3.56 Billion in 2025, is projected to exhibit a CAGR of 5.9% and reach USD 5.32 Billion by 2032.
Market growth is primarily driven by the rising prevalence of periodontal diseases, increasing geriatric population, and growing awareness regarding oral health and aesthetics. Advancements in minimally invasive surgical techniques, the adoption of regenerative dental procedures, and the availability of innovative biomaterials and grafting solutions are further supporting the market expansion.
Additionally, increased dental care expenditure, expanding clinical research for novel treatment approaches, and the rising number of dental visits in both developed and emerging economies are expected to drive the market growth over the forecast period.
Market Takeaways
Gingival Recession Market Report Coverage
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/gingival-recession-market
Report Coverage |
Details |
Market Revenue in 2025 |
USD 3.56 Billion |
Estimated Value by 2032 |
USD 5.32 Billion |
Growth Rate |
Poised to exhibit a CAGR of 5.9% |
Historical Data |
2020-2024 |
Forecast Period |
2025–2032 |
Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
Growth Drivers |
|
Trends |
|
Opportunities |
|
Restraints & Challenges |
|
Market Dynamics
The gingival recession market is experiencing steady growth, driven by the rising prevalence of periodontal diseases, an increasing geriatric population, and heightened awareness of oral health and dental aesthetics. Growing patient preference for minimally invasive procedures and advancements in periodontal treatment techniques are enabling early intervention and improved clinical outcomes. Soft tissue grafting continues to be the most widely adopted approach, while regenerative procedures and the Pinhole Surgical Technique (PST) are gaining popularity due to faster recovery times and enhanced cosmetic results.
Innovation in biomaterials and regenerative solutions is a key market driver, with companies investing in tissue regenerative materials, growth factors, and bioactive membranes to enhance treatment efficacy and long-term success rates. Clinical research is further expanding the scope of novel grafting materials and minimally invasive approaches, which are expected to shape the future of gingival recession treatment. Additionally, increasing dental expenditure, rising dental tourism in emerging markets, and the expansion of specialized dental clinics are contributing to market growth.
In July 2024, BioCellgraft introduced OraFyl, a next-generation human connective tissue matrix (HCTM) therapy for soft and hard tissue enhancement. OraFyl is designed to address periodontal and general dental conditions, demonstrating significantly improved patient outcomes compared to current standard treatments. Clinical partners have successfully conducted multiple cases confirming OraFyl’s efficacy in managing periodontal disease, dental implants, gingival conditions, and other oral‑maxillofacial indications by treating the underlying soft and hard tissue deficiencies.
Market Trends
An emerging trend in high-end cosmetic dentistry is the merging of dental care with skincare-inspired wellness treatments—termed “skinification.” Clinics are introducing multi-step oral therapies such as LED light treatments, gum serums, bacterial biofilm remediation, and even “oral detoxes,” all designed to promote both gum health and aesthetic enhancement. This shift reflects growing consumer demand for a wellness-driven, cosmetic approach to periodontal care, elevating gingival recession treatments beyond simple root coverage toward holistic facial aesthetics and preventive health.
In May 2024, according to an article published on Cosmetics Design Asia, consumers in China, Japan, and South Korea have increasingly embraced skincare-inspired oral care over the past few years. Brands such as Blispring, Colgate (China), and Gentist are incorporating skincare hero ingredients like hyaluronic acid, niacinamide, and probiotics into toothpastes and mouth gels. These formulations aim to nourish gums, reduce inflammation, and brighten teeth—essentially functioning as a skincare regimen for the mouth. This marks a clear extension of the “oral beauty” concept, transitioning from traditional oral hygiene toward dental wellness and aesthetics.
Clinicians and patients are increasingly favoring biologic therapies—including platelet-rich fibrin (PRF), advanced PRF (A‑PRF), leucocyte‑PRF (L‑PRF), enamel matrix derivatives (EMD), and injectable tissue matrices—for managing gingival recession. These approaches are gaining popularity due to their minimally invasive nature, enhanced healing potential, and utilization of autologous or bioengineered materials.
A randomized controlled trial (RCT) published in BMC Oral Health in January 2025 evaluated A‑PRF combined with the VISTA technique for gingival recession treatment. The study demonstrated superior root coverage and increased keratinized gingiva thickness compared to the use of collagen matrices alone, highlighting improved soft tissue regeneration and reduced invasiveness with biologic adjuncts.
Market Opportunities
The growth of dental tourism is creating major opportunities for gingival recession treatments, especially in cosmetic and aesthetic periodontal care. Rising awareness of dental aesthetics is driving patients to seek high-quality procedures that improve both function and appearance. Patients from North America and Europe are increasingly traveling to India, Thailand, Mexico, and Eastern Europe for treatments like gum contouring, regenerative soft‑tissue grafts, and minimally invasive recession correction at significantly lower costs.
This demand is boosted by bundled dental tourism packages, which combine affordable treatment with travel experiences, and by social media influence, as consumers pursue “picture-perfect” smiles. Clinics in tourism-friendly regions are capitalizing on this trend by offering advanced technologies, regenerative materials, and aesthetic techniques to attract international patients.
The integration of digital dentistry tools—including CBCT imaging, CAD/CAM systems, and intraoral scanning (IOS)—combined with 3D printing and AI-driven planning workflows, is ushering in a new era of precision periodontal treatment. This digital transformation enhances diagnosis, treatment planning, and surgical accuracy for soft‑tissue procedures such as gingival recession correction.
In August 2023 study published in the Journal of Clinical Medicine introduced a CBCT-based design workflow for fabricating patient-specific 3D‑printed scaffolds for periodontal regeneration. These customized grafts were precisely tailored to match osseous defects, marking a significant advancement toward personalized tissue engineering and improving outcomes in periodontium restoration.
Analyst View
Competitive Landscape
Gingival Recession Market Segmentation
Regional Insights
Related Reports :